Skip to Main Content

News & Resources

Categories

Recall On Orajel

URM #61710 Orajel baby teething 3/.33oz

URM #61715 Orajel teething day/night 6/.36oz

URM #62335 Orajel baby nitetime 3/.18oz

“The FDA has requested that manufacturers of benzocaine-containing products with indications for the relief of pain associated with teething, or for children under two years of age discontinue their sale and distribution. This is due to the relationship of benzocaine usage to the incidence of methemoglobinemia, a rare but serious condition. Methemoglobinemia is the result of elevated levels of methemoglobin in the blood and it can potentially be fatal. It causes the amount of oxygen carried through the blood to be greatly reduced. The safety of our consumers and their children is our highest priority.

RECALL PDF